$27.59 $0.45 per serving
Product analysis
Carotenoid Complex brings together plant pigments related to retinal function and antioxidant responses in skin. The combined carotenoid amount does not establish the individual lutein contribution, which matters when comparing eye-focused formulas.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality34
Several plant sources are identified, including marigold and an algae extract. Preparation quality remains uncertain across the combination, especially for ingredients with less source detail.
Ingredient Transparency85
The listed amounts and several sources help with basic serving comparisons. Some preparation details are missing, and the carotenoid total should not be read as a separate lutein amount.
Value For Money43
The vitamin A contribution is inexpensive for the amount supplied. Value for the other carotenoids remains uncertain, so that finding does not settle the value of the wider combination.
Customer Satisfaction75
Customer feedback is positive. The moderate rating pool provides a limited picture of satisfaction without confirming visible eye or skin benefits.
Product Focus55
Eye and skin nutrition are related uses for the carotenoid mix, but individual active amounts matter. The small lycopene and astaxanthin contributions limit expectations for targeted skin effects, and the combination does not establish improved everyday vision.
- Format
Softgel - Container
- 60 Softgel(s)
- Per serving
- $0.45
- Customer rating
- 4.7 · 306 ratings
Goals
Impact
Moderate effect
Vitamin A · 25000 IUAstaxanthin · 1000 mcg
Lutein relates to the pigments in the central part of the retina and the filtering of blue light. That connection does not show that the amount here will improve your everyday vision. The declared carotenoid ingredients and their individual amounts matter; their combined presence is not a guarantee of better sight.
How this product is rated for Eye Health
Ingredient fit49
Vitamin C’s eye-related benefit concerns a defined combination for selected people with age-related macular degeneration.
Goal fit
Vitamin C’s eye-related benefit concerns a defined combination for selected people with age-related macular degeneration.
Dose adequacy
Zeaxanthin: 0.305 mg; Lycopene: 3 mg. These serving amounts do not guarantee better vision.
Pathways17
Lutein relates to macular pigment and blue-light filtering; this role does not guarantee a noticeable vision improvement.
Depth
Lutein relates to macular pigment and blue-light filtering; this role does not guarantee a noticeable vision improvement.
Breadth
Vitamin A relates to the visual cycle, while other nutrients relate to antioxidant functions; these roles do not show broad improvement in sight.
Evidence100
Vitamin C’s eye-related benefit concerns a defined combination for selected people with age-related macular degeneration.
Evidence strength
Vitamin C’s eye-related benefit concerns a defined combination for selected people with age-related macular degeneration.
Studied preparation
The declared nutrient forms do not by themselves show that the complete eye-health combination is reproduced.
Formulation logic92
No particular ingredient conflict is identified.
Partner coverage
No missing required ingredient partner is identified.
Conflicts
No particular ingredient conflict is identified.
Effective doses
Zeaxanthin: 0.305 mg; Lycopene: 3 mg. These serving amounts do not guarantee better vision.
carotenoids Not classified
No linked studies yet.
Impact
Moderate effect
Astaxanthin · 1000 mcgLycopene · 3000 mcg
Lycopene and the declared carotenoid material relate mainly to antioxidant responses involved in UV-related skin changes. The 3 mg lycopene amount provides only partial support in the saved findings, and the carotenoid total should not be treated as a separately declared lutein dose. The 1 mg astaxanthin amount contributes little, and these findings do not imply sunscreen-equivalent protection.
How this product is rated for Skin Health
Ingredient fit52
The relevant contribution is prominent alongside ingredients with other purposes. Relevant quantities provide partial support, with smaller or unresolved amounts limiting the finding.
Goal fit
The relevant contribution is prominent alongside ingredients with other purposes.
Dose adequacy
Relevant quantities provide partial support, with smaller or unresolved amounts limiting the finding.
Pathways18
The strongest saved connection is to the skin's collagen and connective-tissue structure. The findings do not show substantial coverage across several distinct skin-health processes.
Depth
The strongest saved connection is to the skin's collagen and connective-tissue structure.
Breadth
The findings do not show substantial coverage across several distinct skin-health processes.
Evidence87
Lycopene supplies the strongest evidence contribution in the saved findings, with the supplied limitations on routine skin benefits retained. The saved findings recognize the relevant preparation at its assessed amount.
Evidence strength
Lycopene supplies the strongest evidence contribution in the saved findings, with the supplied limitations on routine skin benefits retained.
Studied preparation
The saved findings recognize the relevant preparation at its assessed amount.
Formulation logic92
No listed formulation conflict was matched in the saved findings. Unresolved amounts limit the contribution of Vitamin A.
Partner coverage
No required ingredient partner is missing in the saved findings.
Conflicts
No listed formulation conflict was matched in the saved findings.
Effective doses
Unresolved amounts limit the contribution of Vitamin A.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin A (Beta-Carotene) | 25000 IU | |
Broccoli extract (Sulforaphane) | 50 mg | |
Pumpkin seed extract | 25 mg | |
Carrot Seed Oil | 10 mg | |
Lutein (Marigold flower extract) | 5000 mcg | |
Lycopene | 3000 mcg | |
Alpha-Lipoic Acid | 1000 mcg | |
Astaxanthin (Haematococcus pluvialis extract) | 1000 mcg | |
Zeaxanthin (Marigold flower extract) | 305 mcg | |
Alpha-Carotene (D-salina) | 286 mcg |
Vitamin A (Beta-Carotene) · 25000 IU OverallScore60
Each serving provides 25,000 IU of vitamin A from beta-carotene. The total is relatively high.
How this ingredient is rated
Active Ingredient Quality & Bioavailability50
Vitamin A comes from beta-carotene, a provitamin A source.
Vitamin A Chemical Form & Source
Beta-carotene is a provitamin A source.
Dose, Safety & Label Transparency49
The selected serving provides 25,000 IU of vitamin A, a relatively high amount. The source form is identified in the saved information.
Dosage Efficacy & Safety Thresholds
The selected serving provides 25,000 IU of vitamin A, a relatively high amount.
Label Transparency of Specific Forms
Beta-carotene is named; the saved information does not establish a complete source-percentage statement.
Value100
The whole-product price works out to about $0.09 per 5,000 IU of vitamin A. That is low for this vitamin A quantity.
Price per 5,000 IU Dose
The whole-product price works out to about $0.09 per 5,000 IU of vitamin A. That is low for this vitamin A quantity.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Benefits and Safety of Astaxanthin in the Treatment of Mild-To-Moderate Dry Eye Disease.
- Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double-Blind Placebo-Controlled Trial.
- Effects of diet containing astaxanthin on visual function in healthy individuals: a randomized, double-blind, placebo-controlled, parallel study.
- Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential.
- Nutritional Supplementation for Myopia Prevention and Control: A Systematic Review of Randomized Controlled Trials.
- The Associations of Plasma Carotenoids and Vitamins With Risk of Age-Related Macular Degeneration: Results From a Matched Case-Control Study in China and Meta-Analysis.
- Serum carotenoids and risk of age-related macular degeneration in a chinese population sample.
- Serum antioxidants and age-related macular degeneration in a population-based case-control study.
- Association between serum carotenoid concentrations and risk of major age-related eye diseases among middle-aged and older adults.
- Plasma antioxidant vitamins and carotenoids and age-related cataract
- A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
- Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial.
- Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.
- Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity.
- Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy.
- The Protective Role of Astaxanthin for UV-Induced Skin Deterioration in Healthy People-A Randomized, Double-Blind, Placebo-Controlled Trial.
- Supplementating with dietary astaxanthin combined with collagen hydrolysate improves facial elasticity and decreases matrix metalloproteinase-1 and -12 expression: a comparative study with placebo.
- Continuous astaxanthin intake reduces oxidative stress and reverses age-related morphological changes of residual skin surface components in middle-aged volunteers.
- The effectiveness of a standardized rose hip powder, containing seeds and shells of Rosa canina, on cell longevity, skin wrinkles, moisture, and elasticity.
- Cosmetic benefits of astaxanthin on humans subjects.